Who
William E. Delaney IV
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Assembly Biosciences.
In numbers
- Trades disclosed
- 28
- Buys
- 0
- Sells
- 8
- Bought
- $0
- Sold
- $52K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 27 May 2020
- Last trade
- 29 Mar 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Mar 2026filed 5 Jun 2026 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
| 29 Mar 2026filed 5 Jun 2026 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
| 29 Mar 2026filed 31 Mar 2026 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 29 Mar 2026filed 31 Mar 2026 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 29 Mar 2025filed 1 Apr 2025 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,500 at $0.00 | filing |
| 29 Apr 2024filed 1 May 2024 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —3,333 at $0.00 | filing |
| 29 Mar 2024filed 2 Apr 2024 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 3 Oct 2023filed 4 Oct 2023 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $1,5131,891 at $0.80 | filing |
| 2 Oct 2023filed 4 Oct 2023 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 2 Aug 2023filed 3 Aug 2023 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $10K9,461 at $1.09 | filing |
| 22 Jun 2023filed 23 Jun 2023 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 30 May 2023filed 31 May 2023 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $4,0634,232 at $0.96 | filing |
| 23 May 2023filed 24 May 2023 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $6,8236,561 at $1.04 | filing |
| 22 May 2023filed 24 May 2023 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 30 Mar 2023filed 31 Mar 2023 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $2,8053,421 at $0.82 | filing |
| 29 Mar 2023filed 31 Mar 2023 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —140,000 at $0.00 | filing |
| 16 Feb 2023filed 17 Feb 2023 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 1 Aug 2022filed 3 Aug 2022 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 31 May 2022filed 2 Jun 2022 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $7,9954,164 at $1.92 | filing |
| 30 Mar 2022filed 31 Mar 2022 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $2,2521,038 at $2.17 | filing |
News
Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026ASMB · manilatimes.net · 5 Oct 2026
0 headlines in the last 90 days name William E. Delaney IV; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.